GLP-1 Medicines Before Surgery: Questions to Ask

If you take a GLP-1 medicine and have surgery or a procedure coming up, tell the procedure team early. The right plan depends on the exact medicine, your symptoms, why you take it, and the anesthesia involved.

The useful starting point is a shared plan from the professionals prescribing the medicine, performing the procedure, and managing anesthesia. These questions can help you prepare that conversation.

Why does the anesthesia team need to know?

Some GLP-1 medicines slow stomach emptying. The FDA-approved Ozempic prescribing information  describes rare postmarketing reports of pulmonary aspiration during general anesthesia or deep sedation in people receiving GLP-1 receptor agonists. Some had stomach contents remaining despite reportedly following fasting instructions.

Aspiration means material entering the airway or lungs. This concern is one reason medication information belongs in the preprocedure assessment, even when the prescription comes from a different practice.

The label also says evidence is insufficient to determine whether changing fasting recommendations or temporarily stopping Ozempic reduces retained stomach contents. It does not supply a universal pause that guarantees protection.

Who should decide whether the medicine continues?

The multisociety perioperative clinical guidance  emphasizes decisions shared by the patient and the prescribing, procedural, and anesthesia teams. They balance aspiration concerns with the consequences of interrupting treatment. The document acknowledges limited evidence; it is practice guidance rather than proof that one approach is best for everyone.

The American Society of Anesthesiologists' patient explanation  says most patients can continue GLP-1 treatment before surgery, while individual circumstances may call for additional measures. Confirm your team's instructions apply to your current medicine and procedure.

If two offices give different advice, ask them to reconcile it. Confirm who will provide the final plan and how to reach that team if circumstances change.

What information should I send before the procedure?

Provide the active ingredient, brand or product name, formulation, prescribed schedule, and when you last took it. Include recent changes and the reason it was prescribed. A label or accurate medication list is more useful than saying you take “a weight-loss shot.”

The NIDDK information on preparing for upper GI endoscopy  stresses discussing medical history and all prescription medicines, nonprescription products, vitamins, and supplements. That includes products you use only occasionally or obtain from another provider.

Ask where to send this information and confirm the relevant team has received it. Do not assume an outside prescription appears automatically in every facility's records. If the product name is unclear, ask the dispensing pharmacist or prescriber to identify it before relying on a nickname.

Which symptoms and treatment changes matter?

Tell the team about nausea, vomiting, abdominal discomfort, bloating, constipation, or a known condition affecting stomach emptying. Also say whether you recently started treatment or are in a period of increasing it. These are factors the multisociety guidance identifies for assessing risk.

Describe what has changed and when, rather than minimizing a symptom because it seems common. Ask whom to notify if symptoms develop after the assessment but before the procedure. The team may need to reconsider its plan; a previously issued instruction should not prevent you from reporting new information.

What if the medicine is part of diabetes treatment?

The American Diabetes Association's 2026 hospital-care standards  support individualized diabetes management and a discharge plan tailored to the patient. A procedure-related medication decision needs to fit that wider care plan.

Ask who will explain blood-glucose monitoring and instructions for your other diabetes medicines if the plan changes. Provide information about insulin or other treatments you already use. Avoid assuming that another patient's instructions are appropriate for you because both prescriptions have the same name.

Before going home, clarify who handles follow-up questions and how the procedure team's instructions will reach the clinician managing your diabetes.

What should I clarify about preparation and recovery?

Ask for written instructions specific to the planned procedure: which medicines to take or pause, what preparation is required, and when your usual treatment plan should resume. Confirm what to do if the procedure date changes or recovery affects your ability to eat normally.

Depending on the assessment, teams may consider changes to preparation, the anesthesia approach, or the procedure's timing. Ask which measures apply to you and who will explain them. Do not substitute a generic fasting schedule or medication pause for the instructions provided for your care.

Keep the plan with your appointment information and contact the team about anything unclear.

What about compounded or experimental peptide products?

Tell the team about these products too, using their exact names. The FDA's explanation of compounded medicines  notes that compounded preparations are not FDA-approved or verified before marketing for safety, effectiveness, and quality. They should not be described as the approved brand simply because an ingredient name is similar.

Guidance about GLP-1 medicines does not establish the surgical safety of unrelated experimental peptides. A product missing from a familiar medication list is still worth disclosing. Ask the team to review the actual product information rather than applying a GLP-1 instruction to every substance marketed as a peptide.

Frequently asked questions

Should everyone stop a GLP-1 medicine before surgery?

No blanket rule fits every patient. Current multisociety guidance supports an individual assessment, and many patients may continue treatment. Obtain a coordinated plan for your medicine and procedure rather than changing treatment yourself.

Does this also matter before an endoscopy?

It can matter for procedures using general anesthesia or deep sedation, including some endoscopies. Tell the procedure team what you take and ask which anesthesia and medication instructions apply to your appointment.

If I have no nausea, should I still tell the team?

Yes. Medication disclosure is part of the assessment even when you feel well. Report the exact product, recent changes, and relevant history so the team can consider more than symptoms alone.

What if I need an emergency procedure?

Tell the emergency and anesthesia teams about your medicine as soon as possible. Share the product name and when you last took it if you know. Seek needed emergency care promptly; the treating team will assess the precautions required.

Bring procedure questions to a California telehealth discussion

SoCal Testosterone Clinic offers California-only telehealth, with no in-person clinic appointments. Review our peptide service information  and contact the practice about California telehealth care  to ask about a consultation. Bring your medication information and procedure questions. Your procedural and anesthesia teams direct the surgical plan, and the availability or suitability of a particular medicine requires individual clarification.